One year after WTO trade ministers agreed the Doha Declaration on TRIPS and Public Health, the US government, at the behest of giant pharmaceutical companies, continues to bully developing countries to introduce unnecessarily high standards of patent protection on medicines. This continued bilateral pressure restricts and delays the production of cheaper generic medicines, with potentially devastating consequences for millions of poor people.

Authors

Mayne, Ruth

Publication date

01 Nov 2002

ISBN

9781848147164

Publisher

Oxfam International

Series

Oxfam Briefing Papers

Type

Policy paper

Share this page